메뉴 건너뛰기




Volumn 27, Issue 10, 2013, Pages 560-566

Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iprex pre-exposure prophylaxis trial in san francisco

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; DEOXYCYTIDINE; EMTRICITABINE; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR DISOPROXIL;

EID: 84885196472     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2013.0116     Document Type: Article
Times cited : (75)

References (52)
  • 1
    • 78650549662 scopus 로고    scopus 로고
    • Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men
    • Grant RM, Lama JR, Anderson PL, et al. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-2599.
    • (2010) N Engl J Med , vol.363 , pp. 2587-2599
    • Grant, R.M.1    Lama, J.R.2    Anderson, P.L.3
  • 2
    • 84864505868 scopus 로고    scopus 로고
    • Antiretroviral prophylaxis for HIV prevention in heterosexual men and women
    • Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012;367:399-410.
    • (2012) N Engl J Med , vol.367 , pp. 399-410
    • Baeten, J.M.1    Donnell, D.2    Ndase, P.3
  • 3
    • 84864527306 scopus 로고    scopus 로고
    • Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana
    • Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012;367:423-434.
    • (2012) N Engl J Med , vol.367 , pp. 423-434
    • Thigpen, M.C.1    Kebaabetswe, P.M.2    Paxton, L.A.3
  • 4
    • 84879000125 scopus 로고    scopus 로고
    • Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial
    • Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2013;381:2083-2093.
    • (2013) Lancet , vol.381 , pp. 2083-2093
    • Choopanya, K.1    Martin, M.2    Suntharasamai, P.3
  • 6
    • 84880246959 scopus 로고    scopus 로고
    • Use of antiretrovirals for HIV prevention: What do we know and what don't we know?
    • Baeten J, Grant R. Use of antiretrovirals for HIV prevention: What do we know and what don't we know? Curr HIV/AIDS Rep. 2013;10:142-151.
    • (2013) Curr HIV/AIDS Rep. , vol.10 , pp. 142-151
    • Baeten, J.1    Grant, R.2
  • 7
    • 84871777801 scopus 로고    scopus 로고
    • Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: Lessons learned from trials and treatment studies
    • Koenig LJ, Lyles C, Smith, DK. Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studies. Am J Prev Med 2013; 44(1 Suppl 2):S91-S98.
    • (2013) Am J Prev Med , vol.44 , Issue.1 SUPPL. 2
    • Koenig, L.J.1    Lyles, C.2    Smith, D.K.3
  • 8
    • 84860014826 scopus 로고    scopus 로고
    • How well does PrEP work? Unraveling the divergent results of PrEP trials for HIV prevention
    • van der Straten A, van Damme L, Haberer J, et al. How well does PrEP work? Unraveling the divergent results of PrEP trials for HIV prevention. AIDS 2012;26:F13-F19.
    • (2012) AIDS , vol.26
    • Van Der Straten, A.1    Van Damme, L.2    Haberer, J.3
  • 9
    • 79551697351 scopus 로고    scopus 로고
    • Oral preexposure anti-HIV prophylaxis for high-risk U.S. Populations: Current considerations in light of new findings
    • Myers GM, Mayer KH. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: Current considerations in light of new findings. AIDS Patient Care STDs 2011;25:63-71.
    • (2011) AIDS Patient Care STDs , vol.25 , pp. 63-71
    • Myers, G.M.1    Mayer, K.H.2
  • 10
    • 84866283847 scopus 로고    scopus 로고
    • Emtricitabine tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men
    • Anderson PL, Glidden DV, Liu A, et al. Emtricitabine tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med 2012;4:151-125.
    • (2012) Sci Transl Med , vol.4 , pp. 151-125
    • Anderson, P.L.1    Glidden, D.V.2    Liu, A.3
  • 13
    • 84864507852 scopus 로고    scopus 로고
    • Preexposure prophylaxis for HIV infection among African women
    • Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012;367:411-422.
    • (2012) N Engl J Med , vol.367 , pp. 411-422
    • Van Damme, L.1    Corneli, A.2    Ahmed, K.3
  • 14
    • 84878958898 scopus 로고    scopus 로고
    • Pre-exposure prophylaxis for HIV in Women: Daily oral tenofovir, oral tenofovir/emtricitibine, or vaginal tenofovir gel in the VOICE Study (Microbe Trials Network [MTN] 003)
    • Marazzo J, Ramjee G, Nair G, et al. Pre-exposure prophylaxis for HIV in Women: daily oral tenofovir, oral tenofovir/emtricitibine, or vaginal tenofovir gel in the VOICE Study (Microbe Trials Network [MTN] 003). 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 2013;26LB.
    • (2013) 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA
    • Marazzo, J.1    Ramjee, G.2    Nair, G.3
  • 15
    • 84865653865 scopus 로고    scopus 로고
    • HIV and chemoprophylaxis, the importance of considering social structures alongside biomedical and behavioral intervention
    • Roberts ET, Matthews DD. HIV and chemoprophylaxis, the importance of considering social structures alongside biomedical and behavioral intervention. Soc Sci Med 2012;75: 1555-1561.
    • (2012) Soc Sci Med , vol.75 , pp. 1555-1561
    • Roberts, E.T.1    Matthews, D.D.2
  • 20
    • 60649094374 scopus 로고    scopus 로고
    • Social cognition as a mediator of adolescent development: A coactive systems approach
    • Mascolo M, Margolis D. Social cognition as a mediator of adolescent development: A coactive systems approach. Eur J Dev Psych 2004;I:289-302.
    • (2004) Eur J Dev Psych , vol.1 , pp. 289-302
    • Mascolo, M.1    Margolis, D.2
  • 21
    • 0037391631 scopus 로고    scopus 로고
    • Adherence to HAART regimens
    • DOI 10.1089/108729103321619773
    • Chesney M. Adherence to HAART regimens. AIDS Patient Care STDs 2003;17:169-177. (Pubitemid 36444006)
    • (2003) AIDS Patient Care and STDs , vol.17 , Issue.4 , pp. 169-177
    • Chesney, M.1
  • 23
    • 0037313151 scopus 로고    scopus 로고
    • Notions of HIV and medication among multiethnic people living with HIV
    • Oggins J. Notions of HIV and medication among multiethnic people living with HIV. Health Soc Work 2003;28:53-62. (Pubitemid 38569414)
    • (2003) Health and Social Work , vol.28 , Issue.1 , pp. 53-62
    • Oggins, J.1
  • 25
    • 84880220119 scopus 로고    scopus 로고
    • Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai
    • Tangmunkongvorakul A, Chariyalertsak S, Amico KR, et al. Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand. AIDS Care 2012;19:19.
    • (2012) Thailand. AIDS Care , Issue.19 , pp. 19
    • Tangmunkongvorakul, A.1    Chariyalertsak, S.2    Amico, K.R.3
  • 26
    • 84859722634 scopus 로고    scopus 로고
    • What's love got to do with it? Explaining adherence to oral antiretroviral preexposure prophylaxis for HIV-serodiscordant couples
    • Ware NC, Wyatt MA, Haberer JE, et al. What's love got to do with it? Explaining adherence to oral antiretroviral preexposure prophylaxis for HIV-serodiscordant couples. J Acquir Immune Defic Syndr 2012;59:463-468.
    • (2012) J Acquir Immune Defic Syndr , vol.59 , pp. 463-468
    • Ware, N.C.1    Wyatt, M.A.2    Haberer, J.E.3
  • 27
    • 84885228325 scopus 로고    scopus 로고
    • Barriers and facilitators to PrEP adherence in iPrEx: A prevention trial that started in 3 Andean cities
    • Montreal, Canada
    • Goicochea P, Lama J, Vargas L. Barriers and facilitators to PrEP adherence in iPrEx: a prevention trial that started in 3 Andean cities. 15th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 2009; Y162.
    • (2009) 15th Conference on Retroviruses and Opportunistic Infections
    • Goicochea, P.1    Lama, J.2    Vargas, L.3
  • 28
    • 70350754605 scopus 로고    scopus 로고
    • Community involvement in HIV and tuberculosis research
    • Harrington M. Community involvement in HIV and tuberculosis research. J Acquir Immune Defic Syndr 2009;52 (Supp):S63-S66.
    • (2009) J Acquir Immune Defic Syndr , vol.52 , Issue.SUPP
    • Harrington, M.1
  • 29
    • 84893847714 scopus 로고    scopus 로고
    • Could FDA approval of pre-exposure prophylaxis make a difference? A qualitative study of PrEP acceptability and FDA perceptions among men who have sex with men
    • Epub ahead of print: DOI 10.1007/210461-013-0498-9.]
    • Underhill K, Morrow K, Operario D, Mayer K. Could FDA approval of pre-exposure prophylaxis make a difference? A qualitative study of PrEP acceptability and FDA perceptions among men who have sex with men. AIDS Behav 2013. [Epub ahead of print: DOI 10.1007/210461-013-0498-9.]
    • (2013) AIDS Behav
    • Underhill, K.1    Morrow, K.2    Operario, D.3    Mayer, K.4
  • 30
    • 77958176562 scopus 로고    scopus 로고
    • Why the nation needs a policy push on patient centered care
    • Epstein R, Fiscella, K, Lesser CS, et al. Why the nation needs a policy push on patient centered care. Health Aff 2010; 29:1489-1495.
    • (2010) Health Aff , vol.29 , pp. 1489-1495
    • Epstein, R.1    Fiscella, K.2    Lesser, C.S.3
  • 31
    • 33746714993 scopus 로고    scopus 로고
    • Patient-provider relationships HIV, and adherence
    • Apollo A, Golub SA, Wainberg ML, et al. Patient-provider relationships, HIV, and adherence. Soc Work Health Care 2008;42:209-224.
    • (2008) Soc Work Health Care , vol.42 , pp. 209-224
    • Apollo, A.1    Golub, S.A.2    Wainberg, M.L.3
  • 32
    • 84859011117 scopus 로고    scopus 로고
    • Health care disparities and behavioral health among men who have sex with men
    • Alvy LM, McKiman DJ, Du Bois SN, et al. Health care disparities and behavioral health among men who have sex with men. J Gay Lesbian Soc Serv 2011;23:15.
    • (2011) J Gay Lesbian Soc Serv , vol.23 , pp. 15
    • Alvy, L.M.1    McKiman, D.J.2    Du Bois, S.N.3
  • 33
    • 84873621824 scopus 로고    scopus 로고
    • Health care access and health behaviors among men who have sex with men: The cost of health disparities
    • McKiman DJ, Du Bois SN, Alvy LM, et al. Health care access and health behaviors among men who have sex with men: The cost of health disparities. Health Educ Behav 2013; 40:32-41.
    • (2013) Health Educ Behav , vol.40 , pp. 32-41
    • McKiman, D.J.1    Du Bois, S.N.2    Alvy, L.M.3
  • 34
    • 84885214816 scopus 로고    scopus 로고
    • Correlates of study product use among U.S. Participants in the iPrEx randomized controlled trial of daily oral pre-exposure prophylaxis
    • TUPE310
    • Amico KR, Marcus JL, McMahan V, et al. Correlates of study product use among U.S. participants in the iPrEx randomized controlled trial of daily oral pre-exposure prophylaxis. 19th International AIDS Conference Washington, DC, 2012: TUPE310.
    • (2012) 19th International AIDS Conference Washington DC
    • Amico, K.R.1    Marcus, J.L.2    McMahan, V.3
  • 35
    • 33746670549 scopus 로고    scopus 로고
    • An information-motivation-behavioral skills model of adherence to antiretroviral therapy
    • Fisher JD, Fisher W, Amico KR, et al. An information-motivation- behavioral skills model of adherence to antiretroviral therapy. Health Psychol 2006;25:462.
    • (2006) Health Psychol , vol.25 , pp. 462
    • Fisher, J.D.1    Fisher, W.2    Amico, K.R.3
  • 36
    • 84863725804 scopus 로고    scopus 로고
    • Supporting study product use and accuracy in self report in the iPrEx study: Next step counseling and neutral assessment
    • Amico KR, McMahan V, Goicochea P, et al. Supporting study product use and accuracy in self report in the iPrEx study: Next step counseling and neutral assessment. AIDS Behav 2012;16:1243-1259.
    • (2012) AIDS Behav , vol.16 , pp. 1243-1259
    • Amico, K.R.1    McMahan, V.2    Goicochea, P.3
  • 38
    • 45249108765 scopus 로고    scopus 로고
    • Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: A randomized, double-blind, placebo-controlled trial
    • Celum C, Wald A, Hughes J, et al. Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomized, double-blind, placebo-controlled trial. Lancet 2008;371: 2109.
    • (2008) Lancet , vol.371 , pp. 2109
    • Celum, C.1    Wald, A.2    Hughes, J.3
  • 39
    • 13944254982 scopus 로고    scopus 로고
    • Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection
    • Flynn NM, Forthal DN. Harro CD, et al. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis 2005;191:654-665.
    • (2005) J Infect Dis , vol.191 , pp. 654-665
    • Flynn, N.M.1    Forthal, D.N.2    Harro, C.D.3
  • 40
    • 77956596722 scopus 로고    scopus 로고
    • Preliminary analysis of biomedical data from the phase II clinical safety trial of tenofovir disoproxil fumarate (TDF) for HIV-1 preexposure prophylaxis (PrEP) among U.S. Men who have sex with men (MSM)
    • FRLBC102
    • Grohskopf L, Gvetadze R, Pathak S, et al. Preliminary analysis of biomedical data from the phase II clinical safety trial of tenofovir disoproxil fumarate (TDF) for HIV-1 preexposure prophylaxis (PrEP) among U.S. men who have sex with men (MSM). 18th International AIDS Conference, Vienna, Austria, 2010; FRLBC102.
    • (2010) 18th International AIDS Conference, Vienna, Austria
    • Grohskopf, L.1    Gvetadze, R.2    Pathak, S.3
  • 41
    • 84863191544 scopus 로고    scopus 로고
    • Conceptualizing the role of research literacy in advancing societal health
    • Brody J, Dalen J, Annett R, et al. Conceptualizing the role of research literacy in advancing societal health. J Health Psychol 2012;17:724.
    • (2012) J Health Psychol , vol.17 , pp. 724
    • Brody, J.1    Dalen, J.2    Annett, R.3
  • 43
    • 14644444077 scopus 로고    scopus 로고
    • The World Health Organization Last accessed May 29 2013
    • The World Medicines Situation. The World Health Organization, 2004. http://apps.who.int/medicinedocs/en/d/Js6160e/(Last accessed May 29, 2013).
    • (2004) The World Medicines Situation
  • 45
    • 84863064778 scopus 로고    scopus 로고
    • Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in sero-discordant relationships: A mixed methods study
    • Brooks R, Landovitz R, Kaplan R, et al. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in sero-discordant relationships: a mixed methods study. AIDS Patient Care STDs 2012;26:87-94.
    • (2012) AIDS Patient Care STDs , vol.26 , pp. 87-94
    • Brooks, R.1    Landovitz, R.2    Kaplan, R.3
  • 46
    • 84859078297 scopus 로고    scopus 로고
    • Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site
    • Krakower D, Mimiaga M, Rosenberger J, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS One 2012;7:e33119.
    • (2012) PLoS One , vol.7
    • Krakower, D.1    Mimiaga, M.2    Rosenberger, J.3
  • 47
    • 64249143631 scopus 로고    scopus 로고
    • Pre-exposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: Limited knowledge and experience but potential for increased utilization after education
    • Mimiaga M, Case P, Johnson C, et al. Pre-exposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr 2009;50:77-83.
    • (2009) J Acquir Immune Defic Syndr , vol.50 , pp. 77-83
    • Mimiaga, M.1    Case, P.2    Johnson, C.3
  • 49
    • 74049146700 scopus 로고    scopus 로고
    • Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: A randomized controlled trial
    • Simoni J, Huh D, Frick P, et al. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: A randomized controlled trial. J Acquir Immune Defic Syndr 2009;52:465-473.
    • (2009) J Acquir Immune Defic Syndr , vol.52 , pp. 465-473
    • Simoni, J.1    Huh, D.2    Frick, P.3
  • 50
    • 84868323551 scopus 로고    scopus 로고
    • A pilot study using interactive SMS support groups to prevent mother-to-child HIV transmission in South Africa
    • Dean A, Makin J, Kydd A, et al. A pilot study using interactive SMS support groups to prevent mother-to-child HIV transmission in South Africa. J Telemed Telecare 2012;18: 399-403.
    • (2012) J Telemed Telecare , vol.18 , pp. 399-403
    • Dean, A.1    Makin, J.2    Kydd, A.3
  • 51
    • 79953697372 scopus 로고    scopus 로고
    • Online social networking by patients with diabetes: A qualitative evaluation of communication with Facebook
    • Greene J, Choudhry N, Kilabuk E, et al. Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook. J Gen Intern Med 2011;26:287-292.
    • (2011) J Gen Intern Med , vol.26 , pp. 287-292
    • Greene, J.1    Choudhry, N.2    Kilabuk, E.3
  • 52
    • 84870295000 scopus 로고    scopus 로고
    • State of the science of adherence in pre-exposure prophylaxis and microbicide trials
    • Muchomba F, Gearing R, Simoni J, et al. State of the science of adherence in pre-exposure prophylaxis and microbicide trials. J Acquir Immune Defic Syndr 2012;61:490-498.
    • (2012) J Acquir Immune Defic Syndr , vol.61 , pp. 490-498
    • Muchomba, F.1    Gearing, R.2    Simoni, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.